Interações medicamentosas
Bendamustine + Brexucabtagene autoleucel
Gravidade: Grave
Bendamustine and Brexucabtagene autoleucel: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Bendamustine is lymphotoxic and myelosuppressive. Recent exposure before apheresis can reduce T-cell yield and quality, and use after infusion may harm CAR T cells and raise infection risk.
O que esta interação significa em palavras simples
Bendamustine and Brexucabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Bendamustine belongs to Oncology; Brexucabtagene autoleucel belongs to Oncology.
Por que acontece
Additive immunosuppression and lymphodepletion with potential cytotoxicity to T cells.
O que fazer
Observe the recommended washout interval between bendamustine and apheresis, and avoid it after infusion except in a planned lymphodepletion protocol. Monitor blood counts and infections.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Bendamustine e Brexucabtagene autoleucel, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outras interações de Bendamustine
Outras interações de Brexucabtagene autoleucel
Perguntas frequentes
Can I take Bendamustine with Brexucabtagene autoleucel?
MediHelp rates the interaction as major. Bendamustine and Brexucabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Bendamustine is lymphotoxic and myelosuppressive. Recent exposure before apheresis can reduce T-cell yield and quality, and use after infusion may harm CAR T cells and raise infection risk.
How serious is the interaction between Bendamustine and Brexucabtagene autoleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Observe the recommended washout interval between bendamustine and apheresis, and avoid it after infusion except in a planned lymphodepletion protocol. Monitor blood counts and infections.
What other medicines interact with Bendamustine?
MediHelp also lists interactions of Bendamustine with, for example, Axicabtagene ciloleucel, Chlorambucil, Ciltacabtagene autoleucel. The full list is on the Bendamustine page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
